Regenerative Medicine

Smart biomaterials and regenerative medicine have advanced to the peak of innovation and science in Brabant. With a vibrant ecosystem of research institutions, universities, and cutting-edge companies, the region has emerged as a global hub for pioneering breakthroughs in this revolutionary domain. Regenerative medicine, which harnesses the body’s own natural healing abilities to restore or replace damaged tissues and organs, has seen remarkable progress thanks to collaborative efforts and a strong knowledge-sharing culture.

Frontrunner in Smart Biomaterials

Brabant’s expertise in developing smart biomaterials stems from its capacity to create biocompatible materials with specific qualities that allow for precise control of cellular reactions and tissue integration. This synergy of interdisciplinary expertise, state-of-the-art facilities, and a supportive entrepreneurial climate empowers Brabant to excel in regenerative medicine and smart biomaterials, offering the world transformative solutions for regaining health and improving quality of life.

Why Brabant excels in Smart Biomaterials

Research Excellence

The Netherlands has a strong tradition of research excellence in the fields of materials science, bioengineering, and regenerative medicine. Top-notch universities and research institutions conduct pioneering research, leading to breakthroughs in the development of smart biomaterials tailored for regenerative medicine applications.

Interdisciplinary Collaboration

Collaboration between different disciplines, such as materials science, biology, medicine, and engineering, is essential for the advancement of smart biomaterials in regenerative medicine. The Netherlands fosters a collaborative environment, enabling experts from various fields to work together on innovative solutions.

Robust Biotech and Healthcare Industry

The Netherlands has a well-developed biotechnology and healthcare industry, providing a conducive environment for the translation of research findings into practical applications. This includes the development and commercialization of smart biomaterials for regenerative medicine, ensuring a strong market presence.

Government Support and Funding

The Dutch government has shown support for research and innovation in the healthcare sector, including regenerative medicine. Public funding and incentives encourage both academic research and private-sector initiatives in smart biomaterials, driving the development and adoption of these technologies.

Forward-Looking Regulatory Framework

The Netherlands has a regulatory framework that fosters innovation while ensuring patient safety and ethical considerations. This approach provides a balance that allows for the advancement of smart biomaterials in regenerative medicine while maintaining high standards of quality and safety.

Our ecosystem – leading companies & ecosystem locations

Ecosystem Locations
Leading companies

Eindhoven

STENTiT

STENTiT is a leading medical technology company specializing in the development and manufacturing of innovative stents and cardiovascular devices.
VivArt-X

VivArt-X offers a revolutionary synthetic, degradable biomaterial to achieve excellent cell engraftment, which results in personalized breast reconstruction and ultimately regeneration.
Vivolta

Vivolta delivers a full suite of solutions from concept design to large-scale manufacturing of electrospun medical products - both medical devices and drug delivery systems.
Xeltis

Xeltis is a clinical-stage medical device company with the most advanced polymer-based restorative devices for cardiovascular treatment. Xeltis’ devices naturally evolve into living blood vessels or heart valves, when colonized by patient’s own tissue.

Eindhoven

Institute for Complex Molecular Systems (ICMS)

The central goal of this focus area in Complex Molecular Systems is to investigate, design and use intelligent life-like materials that drive the regeneration of living tissues and organs inside the human body.
Smart BioMaterials Consortium (SBMC)

SBMC facilitates the accelerated development and clinical production of smart biomaterials for regenerative medicine, bringing together researchers, entrepreneurs, leading companies, and strategic investors.
Dutch Research Center for Materials-Driven Regeneration

The MDR consortium, funded by the Dutch Government with €18,8 million through the Gravitation program, addresses one of the biggest and costliest challenges of healthcare: the cure of chronic diseases, such as cardiovascular diseases, musculoskeletal disorders, and organ diseases such as kidney failure.

Smart BioMaterials Consortium

SBMC facilitates the accelerated development and clinical production of smart biomaterials for regenerative medicine, bringing together researchers, entrepreneurs, leading companies, and strategic investors. SBMC enables the advancement of product development through shared translational platforms that address critical bottlenecks in the commercialization of regenerative medicine.

Collaborating with renowned research institutions and fostering new ventures, SBMC accelerates the translation of promising technologies, processes, and therapies into transformative health outcomes. High-quality facilities are provided for the industrialization of smart biomaterials and biodegradable implants applied in regenerative medicine-based technologies. SBMC operates as part of the RegMed XB National Pilot factory, which consists of four initiatives forming the national pilot plant for regenerative medicine. Within this framework, SBMC manages a development facility on the Eindhoven University of Technology campus and a pilot production facility. The pilot factory for regenerative medicine is being constructed as part of the growth fund program RegMed XB.

Information leaflet Smart Biomaterials in Brabant

Learn more about Smart Biomaterials in Brabant with this information leaflet

Download

Creating value together with RedMed XB

In the Netherlands, under the slogan “From Care to Cure”, the Regenerative Medicine Top Cluster in the Netherlands is aiming to create regenerative medicine solutions from symptomatic treatment of chronic diseases to prevention and cure. They have united and started a public-private partnership called RegMed XB in 2016. With several medical foundations, top-class researchers, companies, and governmental instances as its members, RegMed XB is actively addressing the ambitious challenges in regenerative medicine and has built a strong infrastructure that brings together top-class experts and companies in the field. At this symposium, RegMed XB and its partner institutions will introduce cutting-edge projects in the Netherlands.